Long COVID – Integrated Approaches to Chronic Disease Management? - 18/12/24
Doi : 10.1016/j.amjmed.2023.04.037
Mark A. Faghy, PhD a, ⁎ 
, Ruth EM Ashton, PhD a, Lindsay Skipper, MA b, Binita Kane, MD c
, Ruth EM Ashton, PhD a, Lindsay Skipper, MA b, Binita Kane, MD c a Biomedical Research Theme, School of Human Sciences, University of Debry, United Kingdom
b Patient and Public Involvement and Engagement Representative, United Kingdom
c Manchester University Foundation Trust and School of Biological Sciences, University of Manchester, United Kingdom
⁎Requests for reprints should be addressed to Dr. Mark Faghy, Biomedical Research Theme, School of Human Sciences, University of Debry, Derby, United Kingdom, DE22 1GB.Biomedical Research Theme, School of Human SciencesUniversity of DebryDerbyDE22 1GBUnited Kingdom
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
El texto completo de este artículo está disponible en PDF.
| Funding: None. |
|
| Conflict of Interest: None. |
|
| Authorship: All authors had access to the data and a role in writing this manuscript. |
© 2023
Elsevier Inc. Reservados todos los derechos.
Vol 138 - N° 1
P. 88-90 - janvier 2025 Regresar al número
Artículo precedente
- Introduction to the Long COVID Mechanisms, Risk Factors, and Recovery: From Cells to Society
- Lawrence D. Hayes
- Long COVID: Clinical Findings, Pathology, and Endothelial Molecular Mechanisms
- H. Bradford Hawley
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.